Article Text
PDFTherapeutics
Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn’s disease
Statistics from Altmetric.com
Footnotes
Source of funding: no external funding.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
2008 by the BMJ Publishing Group Ltd for Evidence-Based Medicine and by the ACP for portions reproduced from ACP Journal Club